LNnT Tetrasaccharide Polymorph Crystallization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for large-scale production of the tetrasaccharide Galpβ1-4GlcNAcpβ1-3Galpβ1-4Glc (LNnT) face challenges due to expensive enzymatic synthesis, complex purification protocols, and low yields, making it difficult to obtain the compound in significant quantities.

Innovation Solution

A method involving the crystallization of LNnT using a water/methanol solution, warming, adding hot methanol, and gradual chilling, along with optional seeding crystals, to produce a stable polymorph with specific X-ray powder diffraction reflections and a melting point between 226-230 °C, facilitating simple and robust purification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If enzymatic synthesis is used to produce LNnT, then LNnT can be obtained with biological activity, but the production cost increases and purification becomes difficult

Engineering Contradiction:
Improvebiological activityVSAvoidproduction cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent changes the chemical parameters of the synthesis process by using chemical glycosylation methods with specific catalysts and protecting groups, replacing enzymatic synthesis. This allows for easier purification through crystallization and reduces production costs while maintaining the ability to produce biologically active LNnT

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts the core structural formation steps from the complex enzymatic system and performs them through targeted chemical glycosylation reactions, eliminating the need for expensive enzymes and complex purification protocols while preserving the biological activity of the final product

Inventive Principle:
Principle #2Taking out (Extraction)

2Quantity of substance

If total synthetic procedures are used to produce LNnT, then LNnT can be obtained, but the number of reaction steps increases and yields decrease

Engineering Contradiction:
ImproveLNnT quantityVSAvoidreaction steps
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent segments the synthesis into a logical sequence: first synthesizing the protected lactosaminyl donor, then performing the key glycosylation reaction to form the LNnT core structure, followed by deprotection. This segmented approach reduces the total number of steps compared to traditional total synthesis while improving overall yield

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary protection of hydroxyl groups and amino groups before the key glycosylation reaction. This preliminary action prevents side reactions, increases the efficiency of the main coupling step, and simplifies subsequent purification, thereby reducing the total number of steps required

Inventive Principle:
Principle #10Preliminary action

3Reliability

If isolation from human milk is used to obtain LNnT, then natural LNnT can be obtained, but the quantity obtained is limited and purification is difficult

Engineering Contradiction:
Improvenatural source purityVSAvoidquantity obtained
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent uses crystallization as an intermediary purification step that enables efficient separation of LNnT from reaction byproducts and impurities. This intermediary process achieves both high purity (comparable to natural isolation) and high productivity (scalable to large quantities), resolving the contradiction between purity and quantity

Inventive Principle:
Principle #24Intermediary (Mediator)

4Ease of manufacture

If crystallization is performed to simplify purification, then purification becomes easier, but the formation of stable polymorphs may limit process flexibility

Engineering Contradiction:
Improvepurification simplicityVSAvoidprocess flexibility
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The patent utilizes phase transition during crystallization to achieve simplified purification. By controlling the phase transition from dissolved to crystalline state through temperature change and solvent removal, the process achieves high purity while maintaining flexibility through adjustable crystallization conditions (temperature, solvent composition, rate of concentration)

Inventive Principle:
Principle #36Phase transitions

Solution Approach 2:

The patent employs parameter changes during crystallization (temperature, solvent composition, concentration rate) to control polymorph formation and maintain process flexibility. These parameter adjustments allow optimization of both purification efficiency and adaptability to different production scales and requirements

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the commercial-scale production of LNnT with high purity, overcoming the limitations of previous methods by providing a cost-effective and efficient route to obtaining LNnT in larger quantities while ensuring its thermodynamic stability and solubility.

Implementation Method 1

warming the LNnT solution to 50-60 °C

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 2

adding hot methanol up to 115-250% of the starting volume to the LNnT solution under gradual chilling to 35-45 °C

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 3

gradual chilling to 35-45 °C

Methodology Applied
Scientific EffectCooling: Cooling

Implementation Method 4

cooling the resulting warm suspension to 0-8 °C

Methodology Applied
Scientific EffectCooling: Cooling

Implementation Method 5

cooling the resulting warm suspension to 0-8 °C

Methodology Applied
Scientific EffectFreezing: Freezing

Data Source

PatentEP3241836B1Polymorph of a tetrasaccharide containing nacetyl-lactosamine
Publication Date: 2024.10.30 GLYCOM AS
  • EP3241836B1 patent drawingFigure 1
  • EP3241836B1 patent drawingFigure 2
  • EP3241836B1 patent drawingFigure 3

AI summary

The present invention relates to a new polymorphic form of the tetrasaccharide of formula (I) and the preperation thereof.